The CVS Health split, announced Wednesday, November 4, 2026, will divide the company into two by early 2028, reversing mergers that joined the nation’s largest drugstore retailer with insurer Aetna and pharmacy benefit manager Caremark. CNN said the company split will have little impact on the way people shop at CVS — the company did not announce any closures — nor will it affect what patients pay for prescriptions. The same day, CVS reported higher third-quarter results and raised full-year guidance.
Key Takeaways
- CVS will split into two companies, with the separation expected to close in early 2028.
- The breakup reverses the 2007 Caremark merger and 2018’s $69 billion Aetna deal.
- Q3 revenue rose 5.4% to $108.4 billion; adjusted EPS was $2.09, up from $1.60.
- No closures were announced; the split will not affect prescription payments.
Inside the CVS Health split
CNN’s report on the breakup said the move unwinds a strategy that began in 2007, when CVS merged with Caremark, and continued in 2018, when CVS acquired Aetna for $69 billion. Shareholders will receive shares of both companies in a tax-free transaction, the company said. The separation is expected to close in early 2028.
“We’re basically taking what I believe is one great company and making it two,” CVS CEO David Joyner said in a statement Wednesday, CNN reported.
On an earnings call, CVS said it has 9,000 locations in the United States, 800 of them MinuteClinics staffed by nurse practitioners and physician assistants, plus 30,000 pharmacists and 200,000 employees in its stores. CNN noted that the drugstores and Caremark insurance already operate separately, and that splitting the companies will not change how they function.
Third-Quarter Results and Raised Guidance
In CVS Health’s third-quarter release, revenue for the three months ended September 30, 2026, rose to $108.4 billion, up 5.4% year over year. GAAP diluted EPS was $1.68, versus a loss of $3.13 a year earlier, reflecting the absence of a $5.7 billion goodwill impairment recorded in the third quarter of 2025. Adjusted EPS was $2.09, up from $1.60, primarily because adjusted operating income improved in Health Care Benefits as that segment executed its margin recovery plan.
CNN said the higher earnings and revenue were due primarily to Health Care Benefits. CVS is raising full-year GAAP diluted EPS, adjusted EPS and cash-flow guidance to reflect increases in Health Care Benefits and Pharmacy & Consumer Wellness, while keeping a cautious view because of elevated cost trends and possible macro headwinds. Year-to-date cash flow from operations was $15.3 billion.
| Metric | Earlier figure | Latest figure |
|---|---|---|
| Q3 GAAP diluted EPS | Loss of $3.13 | $1.68 |
| Q3 adjusted EPS | $1.60 | $2.09 |
| Full-year GAAP diluted EPS | $6.84 to $7.04 | At least $6.98 |
| Full-year adjusted EPS | $7.90 to $8.10 | At least $8.20 |
| Full-year cash flow from operations | At least $11.5 billion | At least $15.5 billion |
Shares of CVS Health, up about 15% so far this year, fell 10% in early trading Wednesday after initially ticking up in the premarket, CNN reported.
Pressure on the Integrated Model
The split is a step back from combining insurers, pharmacy benefit managers and providers into conglomerates. CNN reported that consumer advocates and lawmakers have attacked that consolidation for wielding too much control and raising costs for patients, and that some members of Congress have called for breakups.
Insurers are under cost pressure because Americans are using more health care. Lawmakers and regulators are seeking to reform pharmacy benefit managers as newer players try to chip away at Caremark and other large PBMs. That scrutiny, as CNN described it, is aimed at conglomerate control and benefit-management practices.
What Retail Rivals Should Watch
Michael Cherny of Leerink Partners wrote in a Tuesday client note, after reports of the split surfaced, that CVS’s retail business has been hampered by consumers shifting online, where the company still lags leaders such as Amazon.
Shopper impact, on the facts CVS and CNN have put forward, is limited: no closures were announced, and the split will not affect what patients pay for prescriptions. The company has said the separation is expected to close in early 2028.
- Clinic footprint: 800 MinuteClinics inside the 9,000-location base.
- Store workforce: 30,000 pharmacists and 200,000 employees.
- Guidance also reflects Pharmacy & Consumer Wellness, not only Health Care Benefits.
- Online lag versus Amazon remains the open retail gap, per Leerink.
